|Podcasts|August 23, 2022
SMO, A Model Sustained By Necessity
Author(s)Lisa Henderson, Andy Studna, Senior Editor
Dr. Ian Smith MBE MB ChB.B MedSc(Hons), Founder, Director and Chief Medical Officer of Panthera Biopartners, and Chris Dodd, the company's Chief Commercial Officer, discuss the evolution of the Site Management Organization and Panthera Biopartners, how clinical trials remain mired in underperformance and difficulties, and hybrid trial advancements.
Related Content
Trending on Applied Clinical Trials Online
1
Why Seizure Counts Alone Can't Define Success in Epilepsy Trials
2
Lab Orchestration Is Not What You Think It Is
3
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
4
ACT Brief: Patient Voice in Protocol Design, AI-Informed Recruitment Workflows, and Engagement Maturity Beyond Performative
5